Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Observational 2Interventional 1

Sponsor

Cancer Type

Other 1Breast 1

Conditions

Breast Neoplasms 257Carcinoma, Intraductal, Noninfiltrating 24Breast Carcinoma In Situ 21Neoplasms 12Neoplasm Metastasis 12Breast Neoplasms, Male 12Ovarian Neoplasms 10Inflammatory Breast Neoplasms 7Glioblastoma 6Prostatic Neoplasms 5Endometrial Neoplasms 5Central Nervous System Neoplasms 5Gliosarcoma 4Fallopian Tube Neoplasms 4Breast Cancer Female 4Brain Neoplasms 4Glioma 3Carcinoma, Ovarian Epithelial 3Carcinoma, Ductal, Breast 3Breast Diseases 3Astrocytoma 3Uterine Cervical Neoplasms 2Urinary Bladder Neoplasms 2Sarcoma 2Recurrence 2Pancreatic Neoplasms 2Oligodendroglioma 2Medulloblastoma 2Liver Neoplasms 2Infertility 2

Interventions

Exercise 24Metformin 23Resistance Training 8Nutrition Assessment 8Methods 8Tirzepatide 7Diet Therapy 7Diet 7Counseling 7Early Intervention, Educational 6Caloric Restriction 6Exenatide 5semaglutide 4Liraglutide 4Educational Status 4Docosahexaenoic Acids 4Diet, Mediterranean 4Vitamin D 3Therapeutics 3Surveys and Questionnaires 3Sugars 3Standard of Care 3Dexamethasone 3Yoga 2Tablets 2Specimen Handling 2Progestins 2Ovidrel 2Nutritional Status 2Naltrexone 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Obesity × Tamoxifen × Clear all
NCT01758146 2020-03-04

Impact of Obesity on the Efficacy of Endocrine Therapy With Aromatase Inhibitors

Post Graduate Institute of Medical Education and Research, Chandigarh

Phase 3 Unknown
412 enrolled
BreastOther

Breast Neoplasms, Obesity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡